Latest Market News

Wide Open Agriculture advances its lupin protein commercialisation with a strategic China rollout, sustainability validation, and plans for a large-scale Australian facility.

Alterity Therapeutics reports strengthened efficacy signals for ATH434 in Multiple System Atrophy and secures a robust cash position to fuel upcoming Phase 3 trials.

Osteopore Limited reported a 7% year-on-year revenue increase in Q3 CY25, secured Swiss market approval for its implants, and saw a threefold sales surge through its Zimmer Biomet partnership.

Felix Gold Limited has made significant strides in transitioning its Treasure Creek project from exploration to operational readiness, positioning itself as a key domestic supplier of critical antimony for the U.S. market.

Carnaby Resources reports strong September quarter progress, including significant high-grade copper-gold drill results, full JV buyout, and a $12.5 million placement to advance its Greater Duchess project.

Platformo Ltd’s Biztrak software business experienced a 30% revenue decline in Q3 2025 due to deferred demand following changes to Malaysia’s e-invoicing compliance timeline. Despite this, the company maintained strong cash reserves and advanced key product enhancements.

Koba Resources has acquired two significant tin-tungsten projects in Queensland and discovered a promising new uranium prospect in South Australia, backed by a $4.35 million capital raise to accelerate exploration.

Bounty Oil & Gas reported a modest $272,000 in oil revenue for Q3 2025, boosted reserves in Queensland, and plans to restart Surat Basin production in 2026 while navigating ongoing legal challenges offshore Sydney.

Australian Vanadium Limited advances its vertically integrated vanadium strategy with key regulatory approvals, manufacturing expansions, and a new $10 million loan facility, positioning itself for major energy storage projects.

NGX Limited progresses its Malingunde graphite project with key technical studies and downstream qualification, while advancing uranium exploration in Namibia. Market dynamics and regulatory shifts position NGX favorably in the clean energy minerals sector.

Immuron Limited reports progress on its IMM-529 FDA application and a delay in Travelan® clinical trial results due to a U.S. government shutdown, with key data now expected in late November.

NewPeak Metals has completed acquisition of 100% ownership of the Las Opeñas exploration permits in Argentina, with drilling scheduled for early 2026. The company also advances drilling preparations at its Tansey Gold Project in Australia, supported by strong insider buying.